Search Results

There are 156946 results for: content related to: Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-α2 therapy

  1. Epitopes recognized by neutralizing therapy-induced human anti-interferon-α antibodies are localized within the N-terminal functional domain of recombinant interferon-α2

    European Journal of Immunology

    Volume 26, Issue 9, September 1996, Pages: 2155–2159, Klaus-Ulrich Nolte, Gero Günther and Peter von Wussow

    Article first published online : 17 NOV 2005, DOI: 10.1002/eji.1830260929

  2. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

    British Journal of Haematology

    Volume 78, Issue 2, June 1991, Pages: 210–216, P. v. Wussow, D. Jakschies, M. Freund, R. Hehlmann, F. Brockhaus, H. Hochkeppel, M. Horisberger and H. Deicher

    Article first published online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1991.tb04418.x

  3. You have free access to this content
    Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial


    Volume 71, Issue 5, 1 March 1993, Pages: 1828–1834, Otto Prümmer and Delta-P Study Group

    Article first published online : 28 JUN 2006, DOI: 10.1002/1097-0142(19930301)71:5<1828::AID-CNCR2820710518>3.0.CO;2-0

  4. Recombinant interferon-α therapy for acute hepatitis B: a randomized, double-blind, placebo-controlled trial

    Journal of Viral Hepatitis

    Volume 4, Issue 6, November 1997, Pages: 387–394, N. C. Tassopoulos, M. G. Koutelou, H. Polychronaki, M. Paraloglou-Ioannides and S. J. Hadziyannis

    Article first published online : 31 OCT 2003, DOI: 10.1046/j.1365-2893.1997.00072.x

  5. You have free access to this content
    Characterization of anti-interferon-α antibodies appearing during recombinant interferon-α2a treatment

    Clinical & Experimental Immunology

    Volume 89, Issue 3, September 1992, Pages: 330–335, L. E. RöNNBLOM, E. TIENSUU JANSONJ, A. PERERS, K. E. ÖBERG and G. V. ALM

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1365-2249.1992.tb06957.x

  6. Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-αN1 and in vitro studies on the specificity of the antibodies

    British Journal of Haematology

    Volume 86, Issue 1, January 1994, Pages: 216–218, C. M. Brand, L. Leadbeater, R. Budiman, K. Lechner and H. Gisslinger

    Article first published online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1994.tb03283.x

  7. Hepatitis C virus RNA and long-term response to recombinant interferon-α2b in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 2, Issue 2, March 1995, Pages: 97–102, H. Tanno, J. L. Fernández, P. Rendo, N. del Pino, L. Viola, R. Terg and V. Pérez

    Article first published online : 18 DEC 2007, DOI: 10.1111/j.1365-2893.1995.tb00013.x

  8. A double-blind controlled trial of recombinant interferon-α2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels

    Journal of Viral Hepatitis

    Volume 4, Issue 2, March 1997, Pages: 113–119, J. L. Fernández, P. Rendo, N. del Pino, Nephrologists' group for the study of HCV infection and L. Viola

    Article first published online : 27 AUG 2013, DOI: 10.1111/j.1365-2893.1997.tb00213.x

  9. Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 694–703, F. Matsuda, Y. Torii, H. Enomoto, C. Kuga, N. Aizawa, Y. Iwata, M. Saito, H. Imanishi, S. Shimomura, H. Nakamura, H. Tanaka, H. Iijima, H. Tsutsui, Y. Tanaka and S. Nishiguchi

    Article first published online : 29 MAY 2012, DOI: 10.1111/j.1365-2893.2012.01598.x

  10. Pegylated interferon-α2β in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-α2β in a hepatitis C population: Meta-analysis

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 4, April 2007, Pages: 472–476, Huy A Tran, John R Attia, Tracey L Jones and Robert G Batey

    Article first published online : 14 NOV 2006, DOI: 10.1111/j.1440-1746.2006.04771.x

  11. Treatment of mycosis fungoides with recombinant interferon-αza2 alone and in combination with etretinate

    British Journal of Dermatology

    Volume 118, Issue 6, June 1988, Pages: 811–818, K. THESTRUP-PEDERSEN, R. HAMMER, K. KALTOFT, H. SØGAARD and H. ZACHARIAE

    Article first published online : 29 JUL 2006, DOI: 10.1111/j.1365-2133.1988.tb02600.x

  12. Interferon-α2a effects on complement activation and regulation in MS patients

    Acta Neurologica Scandinavica

    Volume 101, Issue 1, January 2000, Pages: 30–35, K.-M Myhr, S Sadallah, T. E Mollnes, S. Meri, H. I Nyland, J Schifferli and C. A Vedeler

    Article first published online : 29 NOV 2012, DOI: 10.1034/j.1600-0404.2000.00013.x

  13. Recombinant interferon α (rIFN-α) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

    Clinical Endocrinology

    Volume 50, Issue 1, January 1999, Pages: 95–100, Roberta Minelli, Lewis E. Braverman, Maria Antonietta Valli, Claudia Schianchi, Mario Pedrazzoni, Franco Fiaccadori, Mario Salvi, Maria Grazia Magotti and Elio Roti

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2265.1999.00616.x

  14. You have free access to this content
    Recombinant interferon-α therapy in patients with follicular lymphoma


    Volume 83, Issue 3, 1 August 1998, Pages: 0–592, H Ozer, PH Wiernik, F Giles and C Tendler

    Article first published online : 9 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19980801)83:3<593::AID-CNCR33>3.0.CO;2-P

  15. You have free access to this content
    Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-α in normal human sera

    Clinical & Experimental Immunology

    Volume 88, Issue 3, June 1992, Pages: 559–562, M. B. HANSEN, M. SVENSON and K. BENDTZEN

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1365-2249.1992.tb06487.x

  16. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha

    Journal of Cellular Physiology

    Volume 135, Issue 2, May 1988, Pages: 324–331, Adele H. Marshall, Deborah Alper and John Hiscott

    Article first published online : 4 FEB 2005, DOI: 10.1002/jcp.1041350221

  17. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: Electrophysiologic follow-up study

    Muscle & Nerve

    Volume 31, Issue 3, March 2005, Pages: 382–385, Angelo Ammendola, Simone Sampaolo, Lucia Ambrosone, Eduardo Ammendola, Gianluca Ciccone, Sergio Migliaresi and Giuseppe Di Iorio

    Article first published online : 27 OCT 2004, DOI: 10.1002/mus.20184

  18. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. comparison with anti-proliferative activity by RIL1-β, RTNF-α, RIFN-γ, RIl4 and their combinations

    International Journal of Cancer

    Volume 45, Issue 2, 15 February 1990, Pages: 334–341, Roberta Mortarini, Filiberto Belli, Giorgio Parmiani and Andrea Anichini

    Article first published online : 17 JUL 2006, DOI: 10.1002/ijc.2910450221

  19. Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha2b

    European Journal of Haematology

    Volume 46, Issue 1, January 1991, Pages: 11–16, Carlo Aul, Norbert Gattermann and Wolfgang Schneider

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1991.tb00507.x

  20. You have free access to this content
    Nitric oxide is an effector molecule in inhibition of tumor cell growth by rIFN-γ-activated rat neutrophils

    International Journal of Cancer

    Volume 71, Issue 2, 10 April 1997, Pages: 223–230, Takao Yamashita, Tetsuro Uchida, Akemi Araki and Fujiro Sendo

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19970410)71:2<223::AID-IJC17>3.0.CO;2-I